中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Home

Chinese Version

Online office

Journal Online

Forthcoming Articles

Current Issue

Next Issue

Earlier Issues

Download

Editorial Board [2019/7/26]

Instructions for Authors [2015/1/26]

Instructions to Contributors [2013/3/25]

Top

Top Downloaded
Top Cited

Links

alljournals

扫描微信二维码，获取更多信息

Short-term effect of combined therapy with Jinlong Capsule (金龙胶囊) and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression

View Full Text View/Add Comment Download reader

KeyWord:Jinlong Capsule transcatheter arterial chemoembolization primary hepatic carcinoma osteopontin clinical efficacy

Author Name	Affiliation	E-mail
Guo-lin Wu	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China	wuguolin28@yahoo.com.cn
Li Zhang	Center for Drug Reevaluation, State Food and Drug Administration, Beijing, 100045, China
Tian-yi Li	Zhejiang Chinese Medical University, Hangzhou, 310053, China
Jiu Chen	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China
Guo-you Yu	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China
Jian-ping Li	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China

Hits: 1037

Download times: 524

Abstract:

Objective??

To observe the clinical combination effect of Jinlong Capsule (金龙胶囊, JLC) and transcatheter arterial chemoembolization (TACE) on the patients with primary hepatic carcinoma (PHC) and JLC’ s influence on serum osteopontin (OPN) expression and elucidate the correlation between the serum OPN level and curative effect of JLC and TACE.